Carl Zeiss Meditec AG (CZMWY)
OTCMKTS · Delayed Price · Currency is USD
52.50
-1.00 (-1.87%)
Oct 7, 2025, 2:03 PM EDT
Carl Zeiss Meditec AG Market Cap
Carl Zeiss Meditec AG has a market cap or net worth of $4.68 billion as of October 7, 2025. Its market cap has decreased by -22.61% in one year.
Market Cap
4.68B
Enterprise Value
5.36B
Revenue
2.56B
Ranking
n/a
PE Ratio
26.53
Stock Price
$52.50
Market Cap Chart
Since July 30, 2002, Carl Zeiss Meditec AG's market cap has increased from 277.97M to 4.68B, an increase of 1,582.44%. That is a compound annual growth rate of 12.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 4.68B | 13.12% |
| Dec 30, 2024 | 4.13B | -57.69% |
| Dec 29, 2023 | 9.77B | -13.29% |
| Dec 30, 2022 | 11.27B | -39.80% |
| Dec 30, 2021 | 18.72B | 56.40% |
| Dec 30, 2020 | 11.97B | 4.92% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |